Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Diagnostic Capital
More »

  • VC Investment: Not Quite Dead?
    T2 said the capital would be used to support clinical programs as well as commercialization of T2Candida(tm), the company's flagship molecular diagnostic test panel designed for ...
    5-15-2013
  • Chicago Plans Biotech Commercialization Center
    Instead, the center has received commitments for space by Diagnostic Photonics, a cancer ... companies, universities and venture capital firms to promote large and small ...
    4-24-2013
  • Collbio Rescues Angel's Collagen Assets
    Collbio was set up by life science financiers Diagnostic Capital, together with former senior management team members Stewart White and Ross Andrews. From its site in Glasgow, ...
    3-18-2013
  • Affymetrix, PerkinElmer Cut Losses in Q4
    ... tax payments, incremental working capital, and prepaid royalties. "We are pleased ... and growing Chinese blood screening and diagnostic markets," Friel said during a ...
    2-1-2013
  • Biggest Biotech Trends of 2012
    ... Intema, Ltd by invalidating all claims of Intema's patent for a diagnostic method to gauge ... Venture Capital: Investors Remain Skittish The quarterly MoneyTree Report by PwC and the ...
    1-15-2013
  • SeraCare Sheds Biorepository Assets, Focuses on IVD
    ... reagents for research and manufacturing of biopharmaceutical and diagnostic products. ... SeraCare went private last year following its $82 million acquisition by Linden Capital ...
    1-4-2013
  • Biggest Biotech Trends of 2012
    ... Intema, Ltd by invalidating all claims of Intema's patent for a diagnostic method to gauge ... Venture Capital: Investors Remain Skittish The quarterly MoneyTree Report by PwC and the ...
    12-26-2012
  • DuBiotech: The Silicon Valley of Biotechnology
    ... An important component is diagnostic services for hospitals. A significant amount of what ... competitive labor costs and the ready access to capital, you can really hit it big here. ...
    11-26-2012
  • FSD Drugs Advance as Women Push for Equal Access
    ... Ph.D., managing director, biotechnology research with Noble Financial Capital Markets. ... Kingsberg noted that the disorders have been included in the Diagnostic and Statistical ...
    11-20-2012
  • Lucky 13 Serial Entrepreneurs
    Biotech giant launched 1980 by eight research scientists and three venture capital groups. ... to develop and commercialize medical diagnostic imaging products, specifically positron ...
    11-12-2012
  • Agenix Nabs Diagnostic Platform and TB Biomarker
    Diagnostics' DiagnostIQ® point-of-care diagnostic technology for all human health ... The transaction equates to something under 20% of the latter's issued share capital. The ...
    10-25-2012
  • PEGylation Technology Licensed for Long-Acting Blood Factor
    from the U.K. with international capital and matched funding from RUSNANO in Russia. ... which is developing a five-minute point-of-care diagnostic for peripheral artery disease. ...
    9-10-2012
  • Developing Technologies for the Developed World
    public health problems in our nation's capital, these problems also bring up an ... medical purposes, which can include a lone nurse or test van) to use a diagnostic test. ...
    9-4-2012
  • The Big Idea for 2009 as Discussed at J.P. Morgan
    IPO activity is unlikely till the Q4, and early-stage venture capital is nonexistent ... Inverness (IMA)-IMA is an emerging-growth $1.5 billion diagnostic company with products ...
    8-13-2012
  • LabCorp Insists It's Doing the Buying For Now
    TPG Capital and Bain Capital Mergermarket are among firms capable of pursuing a deal for ... in part a 15.5% revenue jump for its diagnostic segment, to $6.5 million, due to ...
    8-1-2012

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll